Diabetes: Page 5

  • A picture of the lobby of Boston Scientific's corporate China reception.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Dexcom and Edwards next as earnings season rolls on

    J.P. Morgan analysts expect this week’s results to be “very good” following reports from J&J, Abbott and Intuitive Surgical.

    By • April 23, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet names Ana Maria Chadwick CFO

    Chadwick succeeds Wayde McMillan, who left last year to become CFO for 3M’s health spinoff.

    By • March 21, 2024
  • A picture of Sequel's Twiist automated insulin delivery system.
    Image attribution tooltip
    Courtesy of Sequel Med Tech
    Image attribution tooltip

    Deka’s automated insulin delivery system, powered by patient-led app, gets FDA clearance

    Sequel Med Tech will sell the new system, which integrates with Tidepool’s Loop insulin dosing algorithm.

    By • March 20, 2024
  • Header image for "77% of Companies Are Currently Undertaking or Considering Layoffs"
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Better Therapeutics lays off staff, considers winding down business

    The digital therapeutics developer received authorization for a Type 2 diabetes treatment app last year but has struggled for money.

    By • March 15, 2024
  • A person playing pickleball wears a circular patch on their upper arm.
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s over-the-counter nod sets stage for broader CGM use

    The FDA’s decision allows people who don’t take insulin, including those who don’t have diabetes, to use the devices without a prescription.

    By • March 7, 2024
  • A Roche logo is seen on the side of a building.
    Image attribution tooltip
    Courtesy of Roche
    Image attribution tooltip

    Roche to take on Abbott, Dexcom with its first CGM

    The new sensor is designed to last for 14 days but requires finger-stick calibration.

    By • March 7, 2024
  • Nick Jonas, Dexcom
    Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit
    Image attribution tooltip

    Dexcom receives FDA clearance for first OTC glucose sensor

    The diabetes tech firm is tailoring its software to the 25 million people in the U.S. who have Type 2 diabetes and do not use insulin.

    By • March 6, 2024
  • The Dexcom G7 Continuous Glucose Monitoring (CGM) System
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom, Novo Nordisk call for FDA input on digital diabetes detection devices

    The companies want clarity on what evidence would be needed for new technologies to detect undiagnosed Type 2 diabetes or prediabetes.

    By • March 4, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet sizes up competition as Tandem, Medtronic plan new insulin patch-pumps

    Insulet CEO Jim Hollingshead said the company is “very confident” in its competitive position as rivals develop their own patch pumps.

    By • Feb. 29, 2024
  • the FDA Headquarters
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip

    FDA warns against using smart wearables that claim to measure blood sugar

    Unauthorized smartwatches and smart rings are “manufactured by dozens of companies and sold under multiple brand names,” according to the agency.

    By • Feb. 23, 2024
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet wins CE mark for integration of insulin pump with Abbott CGM

    The clearance positions Insulet to sell the integrated Type 1 diabetes product in Europe beginning in the first half of the year.

    By • Feb. 8, 2024
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020, in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA extends deadline for comments on role of digital health in diabetes detection

    The agency is seeking answers on how digital health technologies could be used in the detection of prediabetes and Type 2 diabetes.

    By • Jan. 31, 2024
  • Abbott Laboratories
    Image attribution tooltip
    Courtesy of Abbott
    Image attribution tooltip

    Abbott says all four segments stronger than pre-pandemic

    CEO Robert Ford said investing in its base business using COVID-19 testing revenues was “absolutely the right strategy.”

    By • Jan. 24, 2024
  • Signs for Johnson & Johnson are seen on company offices in California.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    3 bellwether companies to watch as medtech earnings season begins

    J&J, Intuitive Surgical and Abbott kick off this week with fourth-quarter reports.

    By • Jan. 22, 2024
  • A smartphone screen reads "Your glucose is steady. Grab a leafy green snack to maintain momentum."
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip

    Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference

    CEO Robert Ford is “very confident” in Abbott’s ability to pass $10 billion in sales of its Libre continuous glucose monitor products by 2028.

    By • Jan. 10, 2024
  • Professional photo of Geoff Martha
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic focused on delivering durable revenue and profit growth

    “Our top priority is restoring our earnings power, full stop,” CEO Geoff Martha said Monday at the J.P. Morgan Healthcare Conference.

    By • Jan. 9, 2024
  • Professional photo of Kevin Sayer
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom plans to launch new CGM this summer for people who don’t take insulin

    The company also shared earnings expectations for 2024 at the J.P. Morgan Healthcare Conference.

    By • Jan. 9, 2024
  • A person smiles while wearing a square device on their hip and a round device on their upper arm.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Abbott, Tandem launch new hybrid closed-loop insulin delivery system

    Competitor Medtronic also received a CE mark for a new CGM sensor that can integrate with its 780G pump.

    By • Jan. 8, 2024
  • An embpty bed is surrounded by monitors and hospital equipment.
    Image attribution tooltip
    Martin Barraud via Getty Images
    Image attribution tooltip

    BTIG analysts optimistic medtech will rebound in 2024 after ‘string of rough years’

    Rising interest rates, fears about the impact of GLP-1 drugs and “choppy supply-chain dynamics” dragged on the industry this year, the analysts wrote.

    By • Dec. 18, 2023
  • A person types on a computer with a stethoscope in the background.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem completes US launch of revamped diabetes management platform

    The platform, Tandem Source, combines the features of the company’s legacy t:connect offerings with new data reports.

    By • Dec. 15, 2023
  • From left to right: A white, rectangular device that says "EO," a black device with a screen that says "EOWatch," and a smartphone.
    Image attribution tooltip
    Courtesy of EOFlow
    Image attribution tooltip

    Medtronic scraps plans to buy insulin patch-pump maker EOFlow

    Medtronic cited “multiple breaches” of the companies’ agreements. EOFlow has been embroiled in patent lawsuits with Insulet this year.

    By • Dec. 7, 2023
  • Nick Jonas, Dexcom
    Image attribution tooltip
    Courtesy of Dexcom, Nick Jonas Super Bowl kit
    Image attribution tooltip

    Dexcom, Hologic picked to outperform in 2024: William Blair

    For the medtech industry overall, the analysts wrote that procedure volume growth is likely to normalize after declining due to the COVID-19 pandemic.

    By • Dec. 7, 2023
  • the FDA Headquarters
    Image attribution tooltip
    Sara Silbiger via Getty Images
    Image attribution tooltip

    Unomedical recall of infusion sets tagged as Class I by FDA

    The company notified Tandem Diabetes Care, its sole consignee, in October of the risk for infusion sets to detach from insulin pumps, disrupting insulin delivery.

    By • Nov. 28, 2023
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip
    Q&A

    Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s

    The CEO said the company’s growth expectations have not changed in the near term, even with the rise of weight loss drugs.

    By • Nov. 21, 2023
  • People walk around a vertical screen that reads "Every 23 Seconds"
    Image attribution tooltip
    Permission granted by Abbott
    Image attribution tooltip
    Q&A

    Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access

    Kazemi hopes anyone with diabetes will be able to access the technology, even people who don’t take insulin.

    By • Nov. 17, 2023